We are live on ! Find out more
LOAMS

Lombard Odier Asset Management (Switzerland) Portfolio holdings

AUM $2.63B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.15B
AUM Growth
-$105M
Cap. Flow
-$153M
Cap. Flow %
-13.33%
Top 10 Hldgs %
19.03%
Holding
431
New
73
Increased
184
Reduced
112
Closed
35

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.5M
2
EVH icon
Evolent Health
EVH
+$9.49M
3
RCL icon
Royal Caribbean
RCL
+$8.69M
4
VTR icon
Ventas
VTR
+$7.23M
5
ARGX icon
argenx
ARGX
+$7.04M

Top Sells

Rank Stock Value
1
CIXX
CI Financial Corp.
CIXX
+$27M
2
SCHW
Charles Schwab
SCHW
+$18.3M
3
ABT icon
Abbott
ABT
+$15.6M
4
BEKE icon
KE Holdings
BEKE
+$15.5M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 44.36%
2 Consumer Discretionary 13.29%
3 Technology 13.16%
4 Financials 10.68%
5 Industrials 6.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MFC icon
1
Manulife Financial
MFC
$73.2B
$30.3M 2.65%
906,314
-297,956
-25% -$5.67M
DXCM icon
2
DexCom
DXCM
$33.4B
$27.2M 2.38%
234,291
+19,500
+9% +$2.18M
IQV icon
3
IQVIA
IQV
$40.3B
$22.5M 1.97%
113,252
-9,766
-8% -$2.09M
SCI icon
4
Service Corp International
SCI
$11.4B
$22M 1.92%
320,000
-75,000
-19% -$5.18M
TMO icon
5
Thermo Fisher Scientific
TMO
$222B
$22M 1.92%
38,134
-9,505
-20% -$5.36M
AAPL icon
6
Apple
AAPL
$4.46T
$21.7M 1.89%
131,469
+11,975
+10% +$1.77M
PODD icon
7
Insulet
PODD
$9.95B
$19M 1.66%
59,680
+17,057
+40% +$5.06M
INMD icon
8
InMode
INMD
$871M
$18.1M 1.58%
566,557
+50,000
+10% +$1.71M
MRK icon
9
Merck
MRK
$322B
$17.9M 1.56%
167,830
-14,122
-8% -$1.52M
UNH icon
10
UnitedHealth
UNH
$367B
$17.3M 1.51%
36,654
+735
+2% +$355K
MSFT icon
11
Microsoft
MSFT
$3.73T
$16.8M 1.47%
58,272
+6,724
+13% +$1.72M
BC icon
12
Brunswick
BC
$5.27B
$16.4M 1.43%
200,000
-100,000
-33% -$8.27M
LOW icon
13
Lowe's Companies
LOW
$124B
$16.2M 1.42%
81,235
-13,090
-14% -$2.66M
HOLX
14
DELISTED
Hologic
HOLX
$16.2M 1.42%
201,280
-19,434
-9% -$1.56M
BMY icon
15
Bristol-Myers Squibb
BMY
$130B
$16.2M 1.42%
234,262
-8,971
-4% -$633K
LH icon
16
Labcorp
LH
$26B
$16.2M 1.42%
82,275
-5,858
-7% -$1.21M
SWAV
17
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$15.8M 1.38%
72,904
+30,187
+71% +$5.88M
LLY icon
18
Eli Lilly
LLY
$1.09T
$15.6M 1.36%
45,426
+16,903
+59% +$5.7M
KEYS icon
19
Keysight
KEYS
$58.4B
$15.4M 1.35%
95,522
-3,710
-4% -$630K
ALNY icon
20
Alnylam Pharmaceuticals
ALNY
$29.3B
$15.2M 1.33%
76,103
+19,365
+34% +$4.07M
BMRN icon
21
BioMarin Pharmaceuticals
BMRN
$13.4B
$15.1M 1.32%
155,411
-50,802
-25% -$5.27M
AXP icon
22
American Express
AXP
$231B
$15M 1.31%
90,720
-29,006
-24% -$4.81M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$134B
$15M 1.31%
47,485
+44,951
+1,774% +$13.5M
ELS icon
24
Equity Lifestyle Properties
ELS
$12.5B
$14.6M 1.27%
217,232
-7,925
-4% -$538K
AMP icon
25
Ameriprise Financial
AMP
$49.9B
$14M 1.22%
45,702
-35,000
-43% -$11.5M
1
2 3 4 5

Similar funds

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
ACM
Advance Capital Management Southfield, Michigan $2.64B AUM 13.57% 1-Year Est. Return
CCM
Cerberus Capital Management New York $2.65B AUM 20.18% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s Q1 2023 Portfolio in Review

As of Q1 2023, Lombard Odier Asset Management (Switzerland) held 431 positions worth $1.15B, down 8.4% from $1.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lombard Odier Asset Management (Switzerland) withdrew a net $153M in Q1 2023, closing 35 positions and reducing 112 holdings. Its most notable exit was CI Financial Corp., an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Lombard Odier Asset Management (Switzerland) opened a new position in Evolent Health worth $9.73M.

  • Lombard Odier Asset Management (Switzerland)'s largest Q1 2023 buy was Evolent Health: 300,000 shares worth $9.73M.
  • Lombard Odier Asset Management (Switzerland) added most to Vertex Pharmaceuticals in Q1 2023, an estimated $13.5M increase.
  • Lombard Odier Asset Management (Switzerland)'s biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $18.3M.
  • Lombard Odier Asset Management (Switzerland) fully exited CI Financial Corp. in Q1 2023, selling an estimated $27M.
  • Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 19% of its $1.15B portfolio in Q1 2023.
  • Lombard Odier Asset Management (Switzerland) opened 73 new positions and closed 35 in Q1 2023.
  • Lombard Odier Asset Management (Switzerland)'s portfolio value fell 8.4% quarter-over-quarter to $1.15B.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 15 May 2023.